InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Guggenhime Andrew, Chief Financial Officer. Insider active across 1 company, notably Vaxcyte, Inc.. Cumulatively, 52 disclosures have been logged. Split: 0 buy · 5 sells. Total volume traded: €968k. History available since 18 November 2021. The latest transaction was disclosed on 3 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Guggenhime Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations52 total
10,000 shares@ US$5.350.0007% mcap0.9% of flowCommon StockSEC:0001230724-26-000014:0
6,956 shares@ US$53.7610.0047% mcap6.3% of flowCommon StockSEC:0001230724-26-000014:1
3,044 shares@ US$54.1780.0021% mcap2.8% of flowCommon StockSEC:0001230724-26-000014:2
10,000 shares@ US$5.350.0006% mcap1.5% of flowCommon StockSEC:0001230724-26-000012:0
7,913 shares@ US$57.1570.0054% mcap12.8% of flowCommon StockSEC:0001230724-26-000012:1
2,087 shares@ US$57.7640.0014% mcap3.4% of flowCommon StockSEC:0001230724-26-000012:2
10,000 sharesCommon StockSEC:0001230724-26-000010:0
10,000 sharesCommon StockSEC:0001230724-26-000010:1
1,021 shares@ US$59.321.4% of flowCommon StockSEC:0001230724-26-000008:0
44,864 shares0Common StockSEC:0001230724-26-000006:0
61,850 shares0Common StockSEC:0001230724-26-000002:0
2,890 shares@ US$32.412.2% of flowCommon StockSEC:0001230724-25-000008:0
1,270 shares@ US$31.561.0% of flowCommon StockSEC:0001230724-25-000007:0
4,777 shares@ US$20.933.6% of flowCommon StockSEC:0001649094-25-000049:0
22,761 shares0Common StockSEC:0001649094-25-000043:0
8,000 shares@ US$5.351.6% of flowCommon StockSEC:0001649094-25-000014:0
8,000 shares@ US$5.351.6% of flowCommon StockSEC:0001649094-25-000008:0
8,000 shares@ US$5.351.6% of flowCommon StockSEC:0001649094-24-000126:0
8,000 shares@ US$5.351.6% of flowCommon StockSEC:0001649094-24-000112:0
19,108 shares@ US$20.9314.5% of flowCommon StockSEC:0001649094-24-000084:0
8,000 shares@ US$5.351.6% of flowCommon StockSEC:0001649094-24-000082:0
8,000 shares@ US$5.351.5% of flowCommon StockSEC:0001649094-24-000071:0
6,337 shares@ US$110.1524.9% of flowCommon StockSEC:0001649094-24-000065:0
8,000 shares@ US$5.351.5% of flowCommon StockSEC:0001649094-24-000054:0
8,000 shares@ US$5.351.5% of flowCommon StockSEC:0001649094-24-000038:0
25 of 52 declarations
About Guggenhime Andrew
GUGGENHIME ANDREW is Directeur Financier at Vaxcyte, Inc. (PRESIDENT AND CFO). He has 49 filings in total, and across the recent sample of 49 filings, the transactions run from 2021-11-22 to 2026-07-06, with EUR 0 in buys and EUR 500831 in sells. The most common transaction type is Levée d'options.
